Artificial intelligence is reshaping drug development not by delivering sudden scientific breakthroughs, but by attacking the slowest, most failure-prone parts of the pharmaceutical pipeline. While the promise of AI-discovered blockbuster molecules remains largely aspirational, drugmakers are already deploying the technology… Read More ›